Diabetes Type 1 and Type 2 are two general classifications for chronic illness marked by elevated blood sugar levels. There is, however, a newer kind of diabetes that shares traits with both Type ...

Singer Lance Bass' efforts to eat right, exercise and take medication weren't helping to manage his newly diagnosed Type 2 ...

Three years ago, a doctor diagnosed me with Type 2 diabetes after a blood test showed a high A1C level. He wrote me a prescription and sent me on my way without information or instructions ...

What alcohol can people with type 2 diabetes drink? No alcohol is completely off-limits for people with diabetes. You are probably better off, however, if you choose drinks that have fewer ...

In several countries, including China, Mexico, and the United States, the incidence of type 2 diabetes now exceeds that of type 1 diabetes among patients younger than 20 years. “This is an ...

Ozempic (semaglutide) and Victoza (liraglutide) are prescription drugs used to treat type 2 diabetes and reduce the risk of cardiovascular problems. Both drugs come as an injection. Ozempic and ...

In the current retrospective study, "SARS-CoV-2 Infection and New-Onset Type 2 Diabetes Among Pediatric Patients, 2020 to 2022," published in JAMA Network Open, researchers looked to see if a ...

Treatment for T2D typically begins with oral antidiabetic agents and a reduction in glycated haemoglobin A1c (HbA1c) — a reflection of glucose levels over the preceding 3 months — to below 7% ...

Eli Lilly shares are up 63% in 2024, buoyed by the company's type 2 diabetes drug Mounjaro and its newcomer, Zepbound. Analysts think highly of the stock. Barclays' Carter Gould has maintained a ...

Ozempic is an FDA-approved medication for treating type 2 diabetes. Its active ingredient is semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that acts like the GLP-1 hormone ...

Conclusions: The intensive lifestyle intervention produced long-term beneficial changes in diet, physical activity, and clinical and biochemical parameters and reduced diabetes risk. This type of ...

In another trial of 91 patients with uncontrolled type 2 diabetes on basal/premixed insulin, Gan & Lee's once-daily GZR101 lowered HbA1c by 1.56%, winning out over the 1.31% reduction in the once ...